The Studio at Kendall Square

Elias Zerhouni and Andy Plump discuss the future of multispecific biologics


Listen Later

Interviewed by Andy Plump, President of R&D at Takeda, Dr. Zerhouni discusses the rationale for multispecifics and the science behind them. They also discuss the differences between pharma and biotech, keys to being an effective R&D leader, and advice for both young and experienced people in their careers.

...more
View all episodesView all episodes
Download on the App Store

The Studio at Kendall SquareBy BiotechTV